This survey indicates that the tumors occurring in women with PJS seem to be slower growing, less likely to recur, and have better prognosis than tumors that are reported in other high-risk breast cancer groups, like BRCA1 and BRCA2 PV carriers. The gene discussed is BRCA2; the disease is breast cancer.